Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.
Fei WuMatthew R SmithAriel L MuellerSeth A KlapmanLucinda L EverettTimothy HouleBraden KuoIon A HobaiPublished in: Canadian journal of anaesthesia = Journal canadien d'anesthesie (2024)
In fasting patients, GLP-1 agonist therapy was associated with an increased incidence of residual gastric contents, potentially posing an additional risk of periprocedural pulmonary aspiration.
Keyphrases
- patients undergoing
- end stage renal disease
- healthcare
- newly diagnosed
- ejection fraction
- insulin resistance
- pulmonary hypertension
- risk factors
- palliative care
- prognostic factors
- peritoneal dialysis
- percutaneous coronary intervention
- type diabetes
- quality improvement
- adipose tissue
- acute coronary syndrome
- skeletal muscle
- weight loss
- pain management
- patient reported outcomes
- smoking cessation
- venous thromboembolism
- affordable care act